Literature DB >> 19003787

Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation.

Leona C Y Poon1, Edgar Zaragoza, Ranjit Akolekar, Evangelos Anagnostopoulos, Kypros H Nicolaides.   

Abstract

OBJECTIVE: To investigate the pathogenesis of pregnancies delivering small for gestational age (SGA) neonates by examining biochemical and Doppler indices of placental development during the first trimester of pregnancy.
METHOD: The concentration of placental growth factor (PlGF) at 11(+0)-13(+6) weeks was measured in 296 cases, which delivered SGA neonates, and 609 controls. The newborn was considered to be SGA if the birth weight was less than the fifth percentile after correction for gestation at delivery and sex, maternal racial origin, weight, height and parity. The distributions of uterine artery pulsatility index (PI), PlGF and PAPP-A, expressed in multiples of the median (MoM), in the control and SGA groups were compared. Logistic regression analysis was used to determine if significant contribution is provided by maternal factors, PlGF, PAPP-A and uterine artery PI in predicting SGA.
RESULTS: The median PlGF (0.900 MoM) and PAPP-A (0.778 MoM) were lower and uterine artery PI was higher (1.087 MoM) in the SGA group than in the controls (PlGF: 0.991 MoM; PAPP-A: 1.070 MoM; uterine artery PI: 1.030 MoM). In the SGA group there was a significant association between PlGF and PAPP-A (r = 0.368, p < 0.0001) and uterine artery PI (r = 0.191, p = 0.001). Significant contributions for the prediction of SGA were provided by maternal factors, PlGF and PAPP-A and with combined screening the detection rate was 27% at a false-positive rate of 5%.
CONCLUSION: Birth weight is predetermined by placental development during the first trimester of pregnancy. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19003787     DOI: 10.1002/pd.2143

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  17 in total

1.  Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia: type 1 versus type 2 preeclampsia?

Authors:  Robert W Powers; James M Roberts; Daniel A Plymire; Dominick Pucci; Saul A Datwyler; Don M Laird; David C Sogin; Arun Jeyabalan; Carl A Hubel; Robin E Gandley
Journal:  Hypertension       Date:  2012-05-29       Impact factor: 10.190

2.  Can Fetal Growth Velocity and First Trimester Maternal Biomarkers Improve the Prediction of Small-for-Gestational Age and Adverse Neonatal Outcome?

Authors:  Manouk L E Hendrix; Judith A P Bons; Roy R G Snellings; Otto Bekers; Sander M J van Kuijk; Marc E A Spaanderman; Salwan Al-Nasiry
Journal:  Fetal Diagn Ther       Date:  2019-05-08       Impact factor: 2.587

3.  Multiomic blood correlates of genetic risk identify presymptomatic disease alterations.

Authors:  Michael Wainberg; Andrew T Magis; John C Earls; Jennifer C Lovejoy; Nasa Sinnott-Armstrong; Gilbert S Omenn; Leroy Hood; Nathan D Price
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-19       Impact factor: 11.205

4.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

5.  Polymorphisms in maternal and fetal genes encoding for proteins involved in extracellular matrix metabolism alter the risk for small-for-gestational-age.

Authors:  Digna R Velez Edwards; Roberto Romero; Juan Pedro Kusanovic; Sonia S Hassan; Shali Mazaki-Tovi; Edi Vaisbuch; Chong Jai Kim; Offer Erez; Tinnakorn Chaiworapongsa; Brad D Pearce; Jacquelaine Bartlett; Lara A Friel; Benjamin A Salisbury; Madan Kumar Anant; Gerald F Vovis; Min Seob Lee; Ricardo Gomez; Ernesto Behnke; Enrique Oyarzun; Gerard Tromp; Ramkumar Menon; Scott M Williams
Journal:  J Matern Fetal Neonatal Med       Date:  2010-07-09

Review 6.  Perspective: L-arginine and L-citrulline Supplementation in Pregnancy: A Potential Strategy to Improve Birth Outcomes in Low-Resource Settings.

Authors:  Andrea M Weckman; Chloe R McDonald; Jo-Anna B Baxter; Wafaie W Fawzi; Andrea L Conroy; Kevin C Kain
Journal:  Adv Nutr       Date:  2019-09-01       Impact factor: 8.701

Review 7.  Adverse pregnancy outcomes after abnormal first-trimester screening for aneuploidy.

Authors:  Laura Goetzl
Journal:  Clin Lab Med       Date:  2010-09       Impact factor: 1.935

8.  Angiogenic and inflammatory biomarkers in midpregnancy and small-for-gestational-age outcomes in Tanzania.

Authors:  Anne Marie Darling; Chloe R McDonald; Andrea L Conroy; Kyla T Hayford; W Conrad Liles; Molin Wang; Said Aboud; Willy S Urassa; Kevin C Kain; Wafaie W Fawzi
Journal:  Am J Obstet Gynecol       Date:  2014-05-29       Impact factor: 8.661

9.  Can placental growth factors explain birthweight variation in offspring of women with type 1 diabetes?

Authors:  Siobhan Bacon; Dylan Burger; Mayur Tailor; J Johanna Sanchez; George Tomlinson; Helen R Murphy; Denice S Feig
Journal:  Diabetologia       Date:  2021-04-10       Impact factor: 10.122

Review 10.  Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis.

Authors:  Yan Zhong; Fufan Zhu; Yiling Ding
Journal:  BMC Pregnancy Childbirth       Date:  2015-08-25       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.